Sichuan Chuanda West China Pharmaceutial Co. Ltd

China

Back to Profile

1-2 of 2 for Sichuan Chuanda West China Pharmaceutial Co. Ltd Sort by
Query
Aggregations
IPC Class
A61K 9/08 - Solutions 2
A61J 3/00 - Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms 1
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines 1
A61K 36/258 - Panax (ginseng) 1
A61K 36/57 - Magnoliaceae (Magnolia family) 1
See more
Found results for  patents

1.

METHOD FOR DETECTING PULSE-ACTIVATING INJECTION INTERMEDIATES

      
Application Number CN2013084415
Publication Number 2015/042852
Status In Force
Filing Date 2013-09-27
Publication Date 2015-04-02
Owner SICHUAN CHUANDA WEST CHINA PHARMACEUTIAL CO., LTD (China)
Inventor
  • Liu, Ya
  • Yao, Zhe
  • Mao, Jie
  • Zhan, Xiangjing
  • Gao, Ning

Abstract

A method for detecting pulse-activating injection intermediates. The pulse-activating injection intermediates comprise red ginseng alcohol extraction liquid, red ginseng water precipitation liquid, radix ophiopogonis first alcohol precipitation liquid, radix ophiopogonis second alcohol precipitation liquid, radix ophiopogonis water precipitation refined liquid through activated carbon, fructus schizandrae first alcohol precipitation liquid, fructus schizandrae second alcohol precipitation liquid, fructus schizandrae water precipitation liquid, fructus schizandrae water precipitation refined liquid through activated carbon, fructus schizandrae distillate and pulse-activating water precipitation filtrate. The detection method comprises detecting ginsenoside content, total solid content and schizandrin content and using HPLC to determine fingerprints of the ginsenoside and the schizandrin. The method can eliminate a technical problem encountered in production timely in an early phase, ensuring quality of the injection.

IPC Classes  ?

  • A61K 36/57 - Magnoliaceae (Magnolia family)
  • A61P 9/00 - Drugs for disorders of the cardiovascular system
  • G01N 30/88 - Integrated analysis systems specially adapted therefor, not covered by a single one of groups
  • G01N 30/02 - Column chromatography
  • G01N 5/04 - Analysing materials by weighing, e.g. weighing small particles separated from a gas or liquid by removing a component, e.g. by evaporation, and weighing the remainder
  • A61K 9/08 - Solutions
  • A61K 36/258 - Panax (ginseng)
  • A61K 36/8968 - Ophiopogon (Lilyturf)

2.

CHINESE HERBAL MEDICINE SHENGMAI INJECTANT PRODUCTION LINE

      
Application Number CN2013084551
Publication Number 2014/114108
Status In Force
Filing Date 2013-09-28
Publication Date 2014-07-31
Owner SICHUAN CHUANDA WEST CHINA PHARMACEUTIAL CO. LTD (China)
Inventor
  • Liu, Ya
  • Yao, Zhe
  • Liu, Xingping
  • Gao, Ning

Abstract

A Chinese herbal medicine Shengmai injectant production line, comprising: a Chinese herbal medicine extraction device, a sterile medicinal liquid transfer device, and a refined Chinese herbal medicine Shengmai injectant formulation device. The production line can complete the production of the Chinese herbal medicine injectant, including medicinal liquid extraction, transportation and formulation.

IPC Classes  ?

  • B01D 11/00 - Solvent extraction
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 9/08 - Solutions
  • A61J 3/00 - Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
  • F17D 3/03 - Arrangements for supervising or controlling working operations for controlling, signalling, or supervising the conveyance of several different products following one another in the same conduit, e.g. for switching from one receiving tank to another